{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:49:26Z","timestamp":1775616566251,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier","isbn-type":[{"value":"9780443431722","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PMP22\/00021"],"award-info":[{"award-number":["PMP22\/00021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.vh.2025.10.006","type":"book-chapter","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T17:58:07Z","timestamp":1763229487000},"page":"265-292","source":"Crossref","is-referenced-by-count":0,"title":["New molecular markers of response to medical therapy in acromegaly"],"prefix":"10.1016","author":[{"given":"Aina","family":"Ravent\u00f3s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Marques-Pamies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"de Pedro-Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carm\u00edn","family":"Puente de la Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pic\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00edas","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edelmiro","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Bernab\u00e9u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Mariaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Marazuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betina","family":"Biagetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Jord\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Puig-Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2025.10.006_bib0001","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0103","article-title":"Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas","volume":"14","author":"Araujo-Castro","year":"2025","journal-title":"Endocrine Connections"},{"key":"10.1016\/bs.vh.2025.10.006_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814002","article-title":"Prolactin and growth hormone signaling and interlink focused on the mammosomatotroph paradigm: A comprehensive review of the literature","volume":"24","author":"Araujo-Castro","year":"2023","journal-title":"International Journal of Molecular Science"},{"key":"10.1016\/bs.vh.2025.10.006_bib0003","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1158\/0008-5472.CAN-07-0219","article-title":"A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors","volume":"67","author":"Asa","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocrine Pathology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3171\/2019.12.JNS192435","article-title":"Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma","volume":"134","author":"Ashton","year":"2021","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/bs.vh.2025.10.006_bib0006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13167-021-00246-1","article-title":"Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies","volume":"12","author":"Aydin","year":"2021","journal-title":"EPMA Journal"},{"key":"10.1016\/bs.vh.2025.10.006_bib0007","doi-asserted-by":"crossref","first-page":"11898","DOI":"10.1021\/acs.analchem.2c02487","article-title":"Metabolomics profiling of pituitary adenomas by Raman spectroscopy, attenuated total reflection-fourier transform infrared spectroscopy, and mass spectrometry of serum samples","volume":"94","author":"Banerjee","year":"2022","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.vh.2025.10.006_bib0008","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0009","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ecl.2020.05.005","article-title":"Update on the genetics of pituitary tumors","volume":"49","author":"Barry","year":"2020","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/bs.vh.2025.10.006_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11910-018-0811-0","article-title":"Genomic alterations in sporadic pituitary tumors","volume":"18","author":"Bi","year":"2018","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/bs.vh.2025.10.006_bib0011","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3390\/jcm8101549","article-title":"Metabolic fingerprint of acromegaly and its potential usefulness in clinical practice","volume":"8","author":"Biagetti","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0012","doi-asserted-by":"crossref","first-page":"984877","DOI":"10.3389\/fendo.2022.984877","article-title":"Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain","volume":"13","author":"Biagetti","year":"2022","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0013","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird","year":"2007","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2025.10.006_bib0014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: A systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.20832","article-title":"Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas","volume":"210","author":"Bottoni","year":"2007","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0016","doi-asserted-by":"crossref","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: The role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0017","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1159\/000531200","article-title":"Clinical and proteomic-based molecular characterizations of invasive and noninvasive somatotroph PitNETs","volume":"113","author":"Chen","year":"2023","journal-title":"Neuroendocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0018","doi-asserted-by":"crossref","first-page":"567021","DOI":"10.3389\/fonc.2020.567021","article-title":"JAG1, regulated by microRNA-424-3p, involved in tumorigenesis and epithelial-mesenchymal transition of high proliferative potential-pituitary adenomas","volume":"10","author":"Chen","year":"2020","journal-title":"Frontiers in oncology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0019","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3892\/ijmm.2020.4807","article-title":"CDKN2A (p16INK4A) affects the anti\u2011tumor effect of CDK inhibitor in somatotroph adenomas","volume":"47","author":"Chen","year":"2021","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0020","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ajpath.2011.07.002","article-title":"Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas","volume":"179","author":"Cheunsuchon","year":"2011","journal-title":"American Journal of Pathology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0021","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/bs.vh.2025.10.006_bib0022","doi-asserted-by":"crossref","unstructured":"Coopmans, E.C., Korevaar, T.I.M., van Meyel, S.W.F., Daly, A.F., Chanson, P., Brue, T., Delemer, B., H\u00e1na, V., Colao, A., Carvalho, D., Jaffrain-Rea, M.-L., Stalla, G.K., Fajardo-Monta\u00f1ana, C., Beckers, A., van der Lely, A.J., Petrossians, P., Neggers (2020). Multivariable prediction model for biochemical response to first-generation somatostatin receptor ligands in acromegaly. The Journal of Clinical Endocrinology and Metabolism, 105, dgaa387. https:\/\/doi.org\/10.1210\/clinem\/dgaa387.","DOI":"10.1210\/clinem\/dgaa387"},{"key":"10.1016\/bs.vh.2025.10.006_bib0023","doi-asserted-by":"crossref","unstructured":"D\u2019Angelo, D., Mussnich, P., Sepe, R., Raia, M., Del Vecchio, L., Cappabianca, P., Pellecchia, S., Petrosino, S., Saggio, S., Solari, D., Fraggetta, F., Fusco, A (2019). RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins. Journal of Molecular Medicine, 97, 1019\u20131032. https:\/\/doi.org\/10.1007\/s00109-019-01789-7.","DOI":"10.1007\/s00109-019-01789-7"},{"key":"10.1016\/bs.vh.2025.10.006_bib0024","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresbull.2020.04.018","article-title":"Comprehensive circular RNA profiling reveals that hsa_circ_0001368 is involved in growth hormone-secreting pituitary adenoma development","volume":"161","author":"Du","year":"2020","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.vh.2025.10.006_bib0025","doi-asserted-by":"crossref","first-page":"101502","DOI":"10.1016\/j.ghir.2022.101502","article-title":"Age, GH\/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study","volume":"67","author":"Durmu\u015f","year":"2022","journal-title":"Growth Hormone & IGF Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/bs.vh.2025.10.006_bib0027","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: Pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0028","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2009-2197","article-title":"The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response","volume":"95","author":"Fougner","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0029","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40618-020-01335-0","article-title":"Somatostatin receptor expression and patients\u2019 response to targeted medical treatment in pituitary tumors: Evidences and controversies","volume":"43","author":"Gatto","year":"2020","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/bs.vh.2025.10.006_bib0030","doi-asserted-by":"crossref","unstructured":"Gil, J., Marques-Pamies, M., Jord\u00e0, M., Fajardo-Monta\u00f1ana, C., Garc\u00eda-Mart\u00ednez, A., Sampedro, M., Serra, G., Salinas, I., Blanco, A., Valassi, E., Sesmilo, G., Carrato, C., C\u00e1mara, R., Lamas, C., Casano-Sancho, P., Alvarez, C.V., Bernab\u00e9u, I., Webb, S.M., Pic\u00f3, A., Marazuela, M., Puig-Domingo, M (2021). Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas. Clinical Endocrinology (Oxf), 94, 811\u2013819. https:\/\/doi.org\/10.1111\/cen. 14339.","DOI":"10.1111\/cen.14339"},{"key":"10.1016\/bs.vh.2025.10.006_bib0031","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1038\/s41598-022-12955-2","article-title":"Data mining analyses for precision medicine in acromegaly: A proof of concept","volume":"12","author":"Gil","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.vh.2025.10.006_bib0032","doi-asserted-by":"crossref","first-page":"dgz096","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: An update","volume":"105","author":"Giustina","year":"2020","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0033","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11102-018-0881-7","article-title":"Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas","volume":"21","author":"Grande","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/bs.vh.2025.10.006_bib0034","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cen.14827","article-title":"Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients","volume":"97","author":"Guaraldi","year":"2022","journal-title":"Clinical Endocrinology (Oxf)"},{"key":"10.1016\/bs.vh.2025.10.006_bib0035","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1210\/jc.2018-01504","article-title":"Hypermethylator phenotype and ectopic GIP receptor in GNAS mutation-negative somatotropinomas","volume":"104","author":"Hage","year":"2019","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0036","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-2008-1065339","article-title":"A short acute octreotide test for response prediction of long-term treatment with somatostatin analogues in acromegalic patients","volume":"40","author":"Halperin","year":"2008","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0037","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12020-015-0766-8","article-title":"Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly","volume":"52","author":"Heck","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0038","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3390\/ijms24032875","article-title":"miR-383-5p, miR-181a-5p, and miR-181b-5p as predictors of response to first-generation somatostatin receptor ligands in acromegaly","volume":"24","author":"Henriques","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.vh.2025.10.006_bib0039","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: Islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nature Reviews Genetics"},{"key":"10.1016\/bs.vh.2025.10.006_bib0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-13-0349","article-title":"Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern","volume":"169","author":"Kasuki","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0041","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: An endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0042","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2015.09.016","article-title":"Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors","volume":"417","author":"Kiseljak-Vassiliades","year":"2015","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0043","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2025.10.006_bib0044","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ncpendmet0324","article-title":"Mechanisms of disease: Mutations of G proteins and G-protein-coupled receptors in endocrine diseases","volume":"2","author":"Lania","year":"2006","journal-title":"Nature Clinical Practice Endocrinology & Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ejendo\/lvad079","article-title":"Predictors of pituitary tumour behaviour: An analysis from long-term follow-up in 2 tertiary centres","volume":"189","author":"Lenders","year":"2023","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0046","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13167-021-00232-7","article-title":"Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches","volume":"12","author":"Li","year":"2021","journal-title":"EPMA Journal"},{"key":"10.1016\/bs.vh.2025.10.006_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2023.102924","article-title":"Predictors of response to treatment with first-generation somatostatin receptor ligands in patients with acromegaly","volume":"54","author":"Marques-Pamies","year":"2023","journal-title":"Archives of Medical Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0048","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/clinem\/dgae444","article-title":"Personalized medicine in acromegaly: The ACROFAST study","volume":"110","author":"Marques-Pamies","year":"2024","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0049","doi-asserted-by":"crossref","first-page":"1269787","DOI":"10.3389\/fendo.2023.1269787","article-title":"Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly","volume":"14","author":"Marques-Pamies","year":"2023","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.23736\/S2724-6507.23.04063-0","article-title":"New molecular tools for precision medicine in pituitary neuroendocrine tumors","volume":"49","author":"Marques-Pamies","year":"2024","journal-title":"Minerva Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-025-01148-2","article-title":"Consensus on acromegaly therapeutic outcomes: An update","author":"Melmed","year":"2025","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0052","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.vh.2025.10.006_bib0053","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1210\/jc.2018-01524","article-title":"Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression","volume":"104","author":"Muhammad","year":"2019","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0054","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.vh.2025.10.006_bib0055","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s00701-021-04953-6","article-title":"Aggressive pituitary neuroendocrine tumors: Current practices, controversies, and perspectives, on behalf of the EANS skull base section","volume":"163","author":"Ng","year":"2021","journal-title":"Acta Neurochirurgica (Wien)"},{"key":"10.1016\/bs.vh.2025.10.006_bib0056","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11154-018-9465-0","article-title":"Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors","volume":"19","author":"Pedraza-Ar\u00e9valo","year":"2018","journal-title":"Reviews in Endocrine and Metabolic Disorders"},{"key":"10.1016\/bs.vh.2025.10.006_bib0057","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing\u2019s disease","volume":"100","author":"Perez-Rivas","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0058","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/10815589231169452","article-title":"Metabolomics in acromegaly: A systematic review","volume":"71","author":"P\u00eenzariu","year":"2023","journal-title":"Journal of Investigative Medicine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0059","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1530\/ERC-16-0356","article-title":"T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly","volume":"23","author":"Potorac","year":"2016","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/bs.vh.2025.10.006_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.12731","article-title":"Treatment of acromegaly in the era of personalized and predictive medicine","volume":"83","author":"Puig Domingo","year":"2015","journal-title":"Clinical Endocrinology (Oxf)"},{"key":"10.1016\/bs.vh.2025.10.006_bib0061","doi-asserted-by":"crossref","first-page":"648411","DOI":"10.3389\/fendo.2021.648411","article-title":"Pasireotide in the personalized treatment of acromegaly","volume":"12","author":"Puig-Domingo","year":"2021","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0062","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1530\/ERC-18-0565","article-title":"Molecular profiling for acromegaly treatment: A validation study","volume":"27","author":"Puig-Domingo","year":"2020","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/bs.vh.2025.10.006_bib0063","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1210\/jc.2010-0573","article-title":"Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure","volume":"95","author":"Puig-Domingo","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0064","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1093\/ejendo\/lvaf100","article-title":"Revised European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumours and pituitary carcinomas","volume":"192","author":"Raverot","year":"2025","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0065","doi-asserted-by":"crossref","first-page":"591039","DOI":"10.3389\/fendo.2020.591039","article-title":"Somatic deletion in exon 10 of aryl hydrocarbon receptor gene in human GH-secreting pituitary tumors","volume":"11","author":"Re","year":"2020","journal-title":"Fronties in Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0066","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2025.10.006_bib0067","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.canlet.2014.10.003","article-title":"MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5","volume":"356","author":"Renjie","year":"2015","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.vh.2025.10.006_bib0068","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/cen.14946","article-title":"Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly","volume":"99","author":"Ruiz","year":"2023","journal-title":"Clinical Endocrinology (Oxf)"},{"key":"10.1016\/bs.vh.2025.10.006_bib0069","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.3390\/cells11233846","article-title":"Transcriptomic classification of pituitary neuroendocrine tumors causing acromegaly","volume":"11","author":"Rymuza","year":"2022","journal-title":"Cells"},{"key":"10.1016\/bs.vh.2025.10.006_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12935-023-02863-4","article-title":"Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues","volume":"23","author":"Saksis","year":"2023","journal-title":"Cancer Cell International"},{"key":"10.1016\/bs.vh.2025.10.006_bib0071","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","article-title":"The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, Cushing\u2019s disease and endocrine-inactive subtypes","volume":"24","author":"Salomon","year":"2018","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0072","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ejendo\/lvae045","article-title":"Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study","volume":"190","author":"Sampedro-Nu\u00f1ez","year":"2024","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0073","doi-asserted-by":"crossref","first-page":"101354","DOI":"10.1016\/j.ghir.2020.101354","article-title":"Efficacy and predictors of short-term first-generation somatostatin analog presurgical treatment in acromegaly: A hospital-based study of 237 cases","volume":"55","author":"Shen","year":"2020","journal-title":"Growth Hormone and IGF Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0074","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/cr.2016.114","article-title":"The genome-wide mutational landscape of pituitary adenomas","volume":"26","author":"Song","year":"2016","journal-title":"Cell Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0075","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.csbj.2021.01.018","article-title":"Review on circular RNAs and new insights into their roles in cancer","volume":"19","author":"Tang","year":"2021","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"10.1016\/bs.vh.2025.10.006_bib0076","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12020-021-02767-1","article-title":"Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas","volume":"74","author":"Tang","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0077","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.3390\/cancers15235685","article-title":"Hotspots of somatic genetic variation in pituitary neuroendocrine tumors","volume":"15","author":"Torres-Mor\u00e1n","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/bs.vh.2025.10.006_bib0078","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and management of pituitary adenomas: A review","volume":"329","author":"Tritos","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/bs.vh.2025.10.006_bib0079","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1210\/jc.2015-3129","article-title":"Whole-Genome sequencing of growth hormone (GH)-secreting pituitary adenomas","volume":"100","author":"V\u00e4lim\u00e4ki","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0080","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1158\/1078-0432.CCR-19-2154","article-title":"A somatostatin receptor subtype-3 (SST3) peptide agonist shows antitumor effects in experimental models of nonfunctioning pituitary tumors","volume":"26","author":"V\u00e1zquez-Borrego","year":"2020","journal-title":"The Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0081","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1111\/jcmm.13851","article-title":"E-cadherin expression is associated with somatostatin analogue response in acromegaly","volume":"23","author":"Venegas-Moreno","year":"2019","journal-title":"The Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0082","article-title":"miR-133 inhibits pituitary tumor cell migration and invasion via down-regulating FOXC1 expression","volume":"15","author":"Wang","year":"2016","journal-title":"Genetics and Molecular Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0083","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12020-022-03155-z","article-title":"Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma","volume":"78","author":"Wang","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0084","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1507\/endocrj.EJ16-0175","article-title":"The value of an acute octreotide suppression test in predicting short-term efficacy of somatostatin analogues in acromegaly","volume":"63","author":"Wang","year":"2016","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.vh.2025.10.006_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coemr.2018.02.001","article-title":"Precision medicine in the medical management of pituitary tumors","volume":"1","author":"Wildemberg","year":"2018","journal-title":"Current Opinion in Endocrine and Metabolic Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0086","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1038\/s41467-018-06853-3","article-title":"Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1\/raptor interaction in pituitary tumours","volume":"9","author":"Wu","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.vh.2025.10.006_bib0087","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/ijms23031413","article-title":"Rno_circ_0001004 acts as a miR-709 molecular sponge to regulate the growth hormone synthesis and cell proliferation","volume":"23","author":"Xiong","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.vh.2025.10.006_bib0088","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s42003-022-04272-1","article-title":"Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas\/somatotroph pituitary neuroendocrine tumors","volume":"5","author":"Yamato","year":"2022","journal-title":"Communications Biology"},{"key":"10.1016\/bs.vh.2025.10.006_bib0089","article-title":"Somatic GNAS mutations in acromegaly: Prevalence, clinical features and gender differences","volume":"14","author":"Yang","year":"2025","journal-title":"Endocrine connections"},{"key":"10.1016\/bs.vh.2025.10.006_bib0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12020-019-02143-0","article-title":"Metabolic profiling of acromegaly using a GC-MS-based nontargeted metabolomic approach","volume":"67","author":"Yu","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/bs.vh.2025.10.006_bib0091","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.acr.2016.01.007","article-title":"Inhibitors of DNA methylation, histone deacetylation, and histone demethylation: A perfect combination for cancer therapy","volume":"130","author":"Zahnow","year":"2016","journal-title":"Advance Cancer Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0092","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pmic.200300408","article-title":"A reference map of a human pituitary adenoma proteome","volume":"3","author":"Zhan","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/bs.vh.2025.10.006_bib0093","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41422-022-00736-5","article-title":"Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors","volume":"32","author":"Zhang","year":"2022","journal-title":"Cell Research"},{"key":"10.1016\/bs.vh.2025.10.006_bib0094","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1210\/jc.2019-00536","article-title":"Exosome-transmitted lncRNA H19 inhibits the growth of pituitary adenoma","volume":"104","author":"Zhang","year":"2019","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2025.10.006_bib0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11060-020-03636-z","article-title":"Comprehensive analysis of the immunological landscape of pituitary adenomas: Implications of immunotherapy for pituitary adenomas","volume":"149","author":"Zhou","year":"2020","journal-title":"Journal of Neuro-Oncology"}],"container-title":["Vitamins and Hormones","Growth Hormone and Related Disorders: From Clinics to Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:05:10Z","timestamp":1775613910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672925000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443431722"],"references-count":95,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2025.10.006","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}